Does Rallies show Form 4 insider transactions for ONCO?

Yes. Rallies tracks ONCO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ONCO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ONCO. It does not provide personalized investment advice.

ONCO (Onconetix, Inc. Common Stock) Stock Analysis - Insider Trades

Onconetix, Inc. Common Stock (ONCO) is a publicly traded Healthcare sector company. As of May 19, 2026, ONCO trades at $0.16 with a market cap of $4.29M and a P/E ratio of -0.06. ONCO moved -47.69% today. Year to date, ONCO is -96.20%; over the trailing twelve months it is -99.15%. Its 52-week range spans $0.31 to $2,762.50. Rallies surfaces ONCO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ONCO stock inside the company?

Recent ONCO insider activity includes HRT FINANCIAL LP sold 49.71K, HRT FINANCIAL LP sold 94.46K, HRT FINANCIAL LP bought 34.64K, HRT FINANCIAL LP sold 53.87K, and HRT FINANCIAL LP bought 92.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ONCO Key Metrics

Key financial metrics for ONCO
Metric	Value
Price	$0.16
Market Cap	$4.29M
P/E Ratio	-0.06
EPS	$-5.14
Dividend Yield	0.00%
52-Week High	$2,762.50
52-Week Low	$0.31
Volume	91.30M
Avg Volume	0
Revenue (TTM)	$735.20K
Net Income	$-9.70M
Gross Margin	79.63%

Recent ONCO Insider Trades

HRT FINANCIAL LP sold 49.71K (~$34.30K) on Apr 21, 2026.
HRT FINANCIAL LP sold 94.46K (~$70.85K) on Apr 20, 2026.
HRT FINANCIAL LP bought 34.64K (~$25.28K) on Apr 17, 2026.
HRT FINANCIAL LP sold 53.87K (~$39.32K) on Apr 16, 2026.
HRT FINANCIAL LP bought 92.55K (~$70.34K) on Apr 15, 2026.

Latest ONCO News

Onconetix Announces 1-for-10 Reverse Split, Shares Jump 23.65% after Proclarix Trial Launch — May 19, 2026
Onconetix’s Proclarix® Cuts Unnecessary Biopsies in 371-Patient Study; U.S. Trial Begins — May 13, 2026
First Vinci AI Vision Robot Delivered to Ericsson, Onconetix to Acquire Realbotix — Apr 9, 2026
Onconetix Readies 19 Robot Deliveries and H2 2026 Acquisition of Realbotix — Apr 2, 2026
Onconetix Appoints David White as CEO to Lead Realbotix Acquisition — Mar 31, 2026

ONCO Analyst Consensus

ONCO analyst coverage data. Average price target: $0.00.

Common questions about ONCO

Who is trading ONCO stock inside the company?: Recent ONCO insider activity includes HRT FINANCIAL LP sold 49.71K, HRT FINANCIAL LP sold 94.46K, HRT FINANCIAL LP bought 34.64K, HRT FINANCIAL LP sold 53.87K, and HRT FINANCIAL LP bought 92.55K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ONCO?: Yes. Rallies tracks ONCO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ONCO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ONCO. It does not provide personalized investment advice.